The pharmacology of the hypouricemic effect of benzbromarone.
D001241:Aspirin / Q000494:pharmacology; D001553:Benzbromarone / Q000494:pharmacology*; D001572:Benzofurans / Q000494:pharmacology*; D001798:Blood Proteins / Q000378:metabolism; D004347:Drug Interactions; D005919:Glomerular Filtration Rate / Q000187:drug effects; D007684:Kidney Tubules / Q000187:drug effects* / Q000378:metabolism; D011485:Protein Binding; D011718:Pyrazinamide / Q000494:pharmacology; D013442:Sulfinpyrazone / Q000494:pharmacology; D014527:Uric Acid / Q000097:blood / Q000378:metabolism*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D001572:Benzofurans; D001798:Blood Proteins; D014527:Uric Acid; D011718:Pyrazinamide; D001553:Benzbromarone; D014969:Xanthine Oxidase; D001241:Aspirin; D013442:Sulfinpyrazone